welcome
Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Health

Health

CorMedix Inc. (CRMD): A Bull Case Theory

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
Summary
Nutrition label

78% Informative

CorMedix Inc. (CRMD)'s share was trading at $ 14.86 as of 12th June .

CRMD’s trailing and forward P/E were 59.44 and 22.88 respectively according to Yahoo Finance .

Its flagship therapy, DefenCath , is designed to prevent catheter-related bloodstream infections in dialysis patients.

VR Score

78

Informative language

78

Neutral language

34

Article tone

formal

Language

English

Language complexity

72

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

Source diversity

1

Affiliate links

no affiliate links